Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Aditxt Inc ADTX

Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc... see more

Recent & Breaking News (NDAQ:ADTX)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTX, RCM, EXTN, ZWS

PR Newswire May 5, 2022

ADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates Aditxt, Inc. - ADTX

Business Wire May 4, 2022

Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore(TM) to Accelerate Adoption and Revenue Growth

Business Wire April 14, 2022

Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th

Business Wire April 5, 2022

Aditxt to Participate in the 2022 Virtual Growth Conference

Business Wire March 23, 2022

ADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates Adequacy of Price and Process in Proposed Sale of Aditxt, Inc. - ADTX

Business Wire March 10, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TMX, SKIL, OCDX, ADTX, MIME

PR Newswire March 7, 2022

ADITXT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Aditxt, Inc. - ADTX

Business Wire March 2, 2022

Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore(TM) for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron

Business Wire January 18, 2022

Aditxt, Inc. to Participate in Edison Group's Global Healthcare "Open House" Virtual Conference From January 25th-27th, 2022

Business Wire January 14, 2022

Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO

Business Wire January 12, 2022

SHAREHOLDER ALERT: WeissLaw LLP Reminds ADTX, LAWS, MNR, and MCFE Shareholders About Its Ongoing Investigations

PR Newswire January 11, 2022

Halper Sadeh LLP Investigates EPAY, VRS, HXOH, OCDX, ADTX; Shareholders are Encouraged to Contact the Firm

PR Newswire January 11, 2022

Shareholder Alert: The M&A Class Action Firm Announces an Investigation of the Merger

PR Newswire January 10, 2022

ADITXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Aditxt, Inc. - ADTX

PR Newswire January 4, 2022

SHAREHOLDER ALERT: WeissLaw LLP Reminds ADTX, LAWS, BPMP, and CSPR Shareholders About Its Ongoing Investigations

PR Newswire January 4, 2022

Halper Sadeh LLP Investigates LAWS, ADTX, SKIL, VRS, BRG; Shareholders are Encouraged to Contact the Firm

PR Newswire January 4, 2022

Halper Sadeh LLP Investigates LAWS, ADTX, EPAY, SKIL, HXOH; Shareholders are Encouraged to Contact the Firm

PR Newswire December 30, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates Aditxt, Inc.

PR Newswire December 29, 2021

Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use

Business Wire December 29, 2021